Find other brokers are proposed as alternative brokers according to administration challenges and/or adverse result profile.  Zidovudine coupled with lamivudine is the choice NRTI backbone but is connected to extra hematologic toxicity. Lopinavir/ritonavir is an alternative PI agent with established security but reveals higher gastrointestinal i… Read More